Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates

INTRODUCTION: The pharmacokinetics of vancomycin are highly variable among neonates, which makes dosing challenging in this population. However, adequate drug exposure is critical, especially when treating methicillin-resistant Staphylococcus aureus (MRSA) infections. Utilization of population pharm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Infect Dis Ther
Main Authors: Stockmann, Chris, Hersh, Adam L., Roberts, Jessica K., Bhongsatiern, Jiraganya, Korgenski, Ernest K., Spigarelli, Michael G., Sherwin, Catherine M. T., Frymoyer, Adam
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2015
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4471056/
https://ncbi.nlm.nih.gov/pubmed/25998107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-015-0067-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares